患者对用于研究目的的残余血液的看法。
Patients' views on residual blood use for research purposes.
作者信息
Hamajima N, Tajima K, Oya H, Kato T, Okuma K, Kaneda H, Moritaka S, Kato T
机构信息
Division of Epidemiology, Aichi Cancer Center Research Institute, Nagoya.
出版信息
Jpn J Cancer Res. 1998 Mar;89(3):341-5. doi: 10.1111/j.1349-7006.1998.tb00568.x.
In order to document patients' views on residual blood use for research purposes, a questionnaire survey was conducted at Aichi Cancer Center Hospital in October 1997. Subjects were patients who had undergone blood tests at a central blood sampling room in the morning during the week of the study enrollment. The questionnaire was handed out and collected at a waiting area in front of the blood sampling room. Of the 583 patients to whom we tried to hand out the questionnaire, 558 participated (258 males, 294 females, and 6 of sex unknown) and 25 refused. Those who regarded research to improve health care as important were 76.7% of those sampled. Only 28 patients (5.0%) answered that they would not permit the use of their residual blood for research purposes. Although logistic analysis did not detect significant factors influencing the giving of permission, the percentage who would not permit the use of their residual blood for research purposes was significantly higher in cancer outpatients (6.7%) than in inpatients (1.0%). It seems desirable for hospitals to establish an open policy concerning residual blood use for research purposes.
为了记录患者对于将剩余血液用于研究目的的看法，1997年10月在爱知癌症中心医院进行了一项问卷调查。研究对象为在研究登记当周的周一至周五上午于中心采血室接受过血液检测的患者。问卷在采血室前的等候区发放并回收。在我们试图发放问卷的583名患者中，558名参与了调查（258名男性，294名女性，6名性别未知），25名拒绝参与。认为改善医疗保健的研究很重要的患者占抽样患者的76.7%。只有28名患者（5.0%）回答他们不会允许将其剩余血液用于研究目的。虽然逻辑分析未发现影响给予许可的显著因素，但癌症门诊患者中不允许将其剩余血液用于研究目的的比例（6.7%）显著高于住院患者（1.0%）。医院似乎应就将剩余血液用于研究目的制定一项开放政策。
Zotero 插件